NEW YORK (GenomeWeb) – PathoQuest, an Institut Pasteur spinout, said today that it has received CE marking for iDTECT Blood, a next-generation sequencing-based metagenomics test for blood pathogens.

The "sample-to-report" test is designed to detect bacteria and viruses in blood samples from patients with suspected infections, especially immunocompromised patients, PathoQuest said.

With the CE mark, PathoQuest will now offer the test through an early-access program in selected countries, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.